MAXIOM Launches Groundbreaking AI-Driven Corporate Wellness Solution — Redefining the Future of Employee Health, Wellness, and Performance
AI is Transforming Corporate Wellness, and MAXIOM is Leading the Charge
PALO ALTO, Calif., June 12, 2025--(BUSINESS WIRE)--MAXIOM, the world's most precise and reliable health and performance AI platform, today announced the launch of its revolutionary corporate wellness solution—setting a new standard for how companies can boost the health and performance of their workforce.
Unlike outdated, expensive, and one-size-fits-all wellness programs, MAXIOM's solution is built from the ground up to be more affordable, more effective, and easier to use. Trained on billions of data sets and the most cited peer-reviewed science, the platform empowers employees with personalized, data-driven guidance that integrates wearable data, biometrics, and nutrition insights into one intuitive dashboard.
"Most corporate wellness programs are outdated, ineffective, and rarely move the needle," said Eric Harr, CEO of MAXIOM. "We built MAXIOM to change that. With Max—the most advanced AI in health and fitness—and expert human coaches always in the loop, employees get hyper-personalized guidance they can trust, while companies get the data they need, simply, to drive real results and boost productivity."
Why MAXIOM is Different
Affordable: A fraction of the cost of traditional wellness programs, with no complex integrations or long onboarding.
Effective: MAXIOM delivers daily, adaptive guidance based on real-time data—personalized nutrition, sleep, exercise, and recovery recommendations that drive sustainable results.
Effortless: Employees connect whatever wearables they already use, complete a short onboarding, and get instant insights. They can interact with Max via natural conversation without digging through data.
Privacy-First Insights
MAXIOM provides companies with anonymized, aggregated data—allowing them to see workforce trends, stress levels, and health risks while ensuring employee privacy. These insights help leadership teams make informed decisions about well-being and productivity.
AI + Human Expertise
MAXIOM blends cutting-edge AI with expert human coaches, ensuring employees get guidance that's not only intelligent but also deeply personal.
Visit: http://maxiom.io/corporate to learn more.
About MAXIOM:
Combining AI, science, and human expertise, MAXIOM is setting the standard for health and fitness optimization worldwide.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250609543851/en/
Contacts
Danielle DenBleykerVP, Business DevelopmentMaxiom Labs, Inc.danielle@maxiom.io
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Jon Hamm and Carvana Launch National Campaign Highlighting the Simpler Way to Sell Your Car
Award-winning actor helps bring Carvana's brand to life in a new campaign that combines humor and relatability to show how easy it is to sell your car online PHOENIX, June 10, 2025--(BUSINESS WIRE)--Carvana (NYSE: CVNA), an industry pioneer for buying and selling used cars online, today announced a new national campaign in collaboration with Emmy and Golden Globe-winning actor Jon Hamm. The campaign highlights how easy it is to sell your car to Carvana, as Hamm brings his signature humor and relatability to a series of new ads launching across digital, broadcast, and streaming platforms. The campaign kicks off with a 30-second spot titled "Excuses," in which Hamm tries to get out of an awkward social obligation by claiming he has to handle the time-consuming task of selling his car. The problem? Carvana makes the process so fast and simple that his excuse immediately unravels, especially since his car is already sold and loaded onto a Carvana hauler just a few feet away. "Jon Hamm's comedic timing brings the entire campaign to life and perfectly highlights how Carvana takes the hassle out of selling a car," said Ryan Keeton, Carvana co-founder and chief brand officer. "We've made it easier than ever to sell your car online, and Jon helps us share that message with the signature humor and charm he's known for." Developed by Carvana's in-house creative team, the campaign will roll out nationwide across digital, broadcast, and streaming platforms starting today. "Excuses" is the first of two commercial spots featuring Hamm that Carvana will debut throughout the year alongside additional social content. The campaign continues Carvana's tradition of pairing engaging talent and lighthearted humor to showcase how Carvana drives its customers happy with a process that's fun, fast, and fair. About Carvana Carvana's mission is to change the way people buy and sell cars. Since launching in 2013, Carvana has revolutionized automotive retail and delighted millions of customers with an offering that is fun, fast, and fair. With Carvana, customers can find a car, get financing, trade in, and complete a purchase entirely online with the convenience of delivery or local pickup as soon as the same day. Carvana's unique offering is powered by its passionate team, differentiated national infrastructure, and purpose-built technology. For more information, please visit View source version on Contacts MEDIA CONTACT: Carvana Communicationspress@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Wire
an hour ago
- Business Wire
Perma-Pipe International Holdings, Inc. Announces First Quarter Fiscal 2025 Financial Results
SPRING, Texas--(BUSINESS WIRE)--Perma-Pipe International Holdings, Inc. (NASDAQ: PPIH) announced today financial results for the first quarter ended April 30, 2025. 'Sales for the first quarter were $46.7 million, resulting in an increase of $12.4 million, or 36.2%, compared to $34.3 million in the same quarter last year. Net income attributable to common stock of $5.0 million was an increase of $3.6 million, or 243%, compared to $1.4 million in the first quarter of the prior year,' noted President and CEO Saleh Sagr. Backlog currently stands at $131.1 million, a decrease of $7.0 million, compared to $138.1 million at January 31, 2025. However, the Company has experienced a significant increase in backlog of $68.0 million, or 108%, compared to $63.1 million at April 30, 2024. We feel encouraged with the level of backlog we have obtained, which remains more than double the level of reported backlog at the end of the first quarter last year,' Mr. Sagr continued. 'Our first quarter results represent unprecedented performance on behalf of the Company as both sales and net income attributable to common stock are the highest levels of performance in the first quarter since transitioning from MFRI to Perma-Pipe in 2017. Additionally, net income attributable to common stock during the first quarter represents approximately 55% of the Company's full year fiscal 2024 results,' noted President and CEO Saleh Sagr. 'We are pleased with the level of business activity we are experiencing in various markets, which contributed to the overall increase in sales and earnings during the first fiscal quarter. Additionally, we are very encouraged by the level of performance in both the Americas and MENA region, which produced comparable results in the first quarter,' Mr. Sagr commented. 'The strength of our first quarter results provides significant momentum heading into the remaining quarters of fiscal 2025. We feel well-positioned that the Company will continue to capitalize on this momentum and drive further participation in development plans in MENA and gain additional market share in the North America region,' Mr. Sagr concluded. First Quarter Fiscal 2025 Results Net sales were $46.7 million and $34.3 million in the three months ended April 30, 2025 and 2024, respectively. The increase of $12.4 million, or 36%, was a result of increased sales volumes in the Middle East and in North America. Gross profit was $16.7 million, or 36% of net sales, and $10.5 million, or 31% of net sales, in the three months ended April 30, 2025 and 2024, respectively. The increase of $6.2 million, was driven primarily by increased volume of activity and better margins due to product mix. General and administrative expenses were $7.7 million and $6.1 million in the three months ended April 30, 2025 and 2024, respectively. The increase of $1.6 million, was due to higher payroll expenses and professional fees in the quarter. Selling expenses remained consistent and were $1.1 million and $1.2 million in the three months ended April 30, 2025 and 2024, respectively. Net interest expense remained consistent and was $0.4 million and $0.5 million in the three months ended April 30, 2025 and 2024, respectively. Other expense remained consistent and was less than $0.1 million in the three months ended April 30, 2025 and 2024, respectively. The Company's ETR was 21% and 30% in the three months ended April 30, 2025 and 2024, respectively. The change in the ETR is due to the mix of income and loss in various jurisdictions. Net income attributable to common stock was $5.0 million and $1.4 million in the three months ended April 30, 2025 and 2024, respectively. The increase of $3.6 million, was mainly due to increased sales volumes and better project execution in the quarter. Perma-Pipe International Holdings, Inc. Perma-Pipe International Holdings, Inc. (the 'Company') is a global leader in pre-insulated piping and leak detection systems for oil and gas gathering, district heating and cooling, and other applications. It uses its extensive engineering and fabrication expertise to develop piping solutions that solve complex challenges regarding the safe and efficient transportation of many types of liquids. In total, the Company has operations at fourteen locations in six countries. Forward-Looking Statements Certain statements and other information contained in this press release that can be identified by the use of forward-looking terminology constitute 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby, including, without limitation, statements regarding the expected future performance and operations of the Company. These statements should be considered as subject to the many risks and uncertainties that exist in the Company's operations and business environment. Such risks and uncertainties include, but are not limited to, the following: (i) fluctuations in the price of oil and natural gas and its impact on customer order volume for the Company's products; (ii) the Company's ability to purchase raw materials at favorable prices and to maintain beneficial relationships with its suppliers; (iii) decreases in government spending on projects using the Company's products, and challenges to the Company's non-government customers' liquidity and access to capital funds; (iv) the Company's ability to repay its debt and renew expiring international credit facilities; (v) the Company's ability to effectively execute its strategic plan and achieve sustained profitability and positive cash flows; (vi) the Company's ability to collect a long-term account receivable related to a project in the Middle East; (vii) the Company's ability to interpret changes in tax regulations and legislation; (viii) the Company's ability to use its net operating loss carryforwards; (ix) reversals of previously recorded revenue and profits resulting from inaccurate estimates made in connection with the Company's "over-time" revenue recognition; (x) the Company's failure to establish and maintain effective internal control over financial reporting; (xi) the timing of order receipt, execution, delivery and acceptance for the Company's products; (xii) the Company's ability to successfully negotiate progress-billing arrangements for its large contracts; (xiii) aggressive pricing by existing competitors and the entrance of new competitors in the markets in which the Company operates; (xiv) the Company's ability to manufacture products free of latent defects and to recover from suppliers who may provide defective materials to the Company; (xv) reductions or cancellations of orders included in the Company's backlog; (xvi) risks and uncertainties specific to the Company's international business operations; (xvii) the Company's ability to attract and retain senior management and key personnel; (xviii) the Company's ability to achieve the expected benefits of its growth initiatives; (xix) the impact of pandemics and other public health crises on the Company and its operations; and (xx) the impact of cybersecurity threats on the Company's information technology systems. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are made only as of the date of this press release and we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. More detailed information about factors that may affect our performance may be found in our filings with the Securities and Exchange Commission, which are available at and under the Investor Center section of our website ( The Company's fiscal year ends on January 31. Years, results, and balances described as 2025, 2024, and 2023 are for the fiscal year ended January 31, 2026, 2025, and 2024, respectively. Additional information regarding the Company's financial results for the fiscal year ended January 31, 2025, including management's discussion and analysis of the Company's financial condition and results of operations, is contained in the Company's Annual Report on Form 10-K for the fiscal year ended January 31, 2025, which will be filed with the Securities and Exchange Commission on or about the date hereof and will be accessible at and For more information, visit the Company's website. PERMA-PIPE INTERNATIONAL HOLDINGS, INC. AND SUBSIDIARIES (In thousands) (Unaudited) April 30, 2025 January 31, 2025 ASSETS Current assets $ 120,700 $ 108,802 Long-term assets 57,615 56,439 Total assets $ 178,315 $ 165,241 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities $ 61,751 $ 54,063 Long-term liabilities 26,459 28,073 Total liabilities 88,210 82,136 Non-controlling interests 12,238 10,967 Stockholders' equity 77,867 72,138 Total liabilities and equity $ 178,315 $ 165,241 Expand
Business Wire
an hour ago
- Business Wire
CORRECTING and REPLACING Smart Meter Selected By 9amHealth for Major Employer Weight Management Programs Using Cellular Weight Scale
TAMPA, Fla.--(BUSINESS WIRE)--Please replace the release dated June 11, 2025 with the following corrected version due to multiple revisions. The updated release reads: SMART METER SELECTED BY 9AMHEALTH FOR MAJOR EMPLOYER WEIGHT MANAGEMENT PROGRAMS USING CELLULAR WEIGHT SCALE Smart Meter, a pioneer in cellular-enabled weight scale technology, today announced a strategic supply agreement with 9amHealth, a leading provider of comprehensive weight management and cardiometabolic benefits for large employers. This collaboration integrates Smart Meter's advanced cellular weight scales into 9amHealth's multi-disciplinary care platform, delivering real-time health data and enhanced outcomes for employees at major technology companies and Fortune 500 organizations. Addressing Critical Gaps in Employee Weight Management for Millions of Americans The partnership addresses a significant challenge identified by leading employers: while lifestyle changes remain the foundation of managing weight, traditional approaches often lack the consistent monitoring and data integration required to achieve and maintain goals. With major tech companies already deploying 9amHealth's solution, the addition of Smart Meter's cellular scales provides seamless, automatic data collection that eliminates barriers to consistent tracking. "We're seeing tremendous demand from large employers who want to move beyond BMI-only assessments and provide their employees with easy-to-use technology to support better weight management," said Casey Pittock, CEO at Smart Meter. "Our cellular scales integrate perfectly with 9amHealth's clinical approach, providing real-time data that allows physicians, pharmacists, and dietitians to deliver personalized care." Enhancing Clinical Care with Real-Time Data 9amHealth's evidence-based program combines physicians, pharmacists, and registered dietitians trained in obesity care, available virtually across all 50 states. The integration of Smart Meter's cellular scales enhances this care model by: Automatic Data Transmission: Eliminating the need for manual weight logging, reducing friction in the patient experience Real-Time Clinical Insights: Enabling care teams to monitor progress and adjust treatment plans promptly Comprehensive Metabolic Monitoring: Supporting early identification of conditions like prediabetes and diabetes Seamless Integration: Connecting directly with 9amHealth's clinical platform without requiring additional apps or devices 'Nearly 10% of new members enrolling in our weight health and cardiometabolic program are found to have previously undiagnosed prediabetes or diabetes,' said Dr. Avantika Waring, MD, Chief Medical Officer at 9amHealth. 'Smart Meter's cellular scales give us consistent, reliable data that supports early identification of risk patterns and enables more personalized interventions—focused on improving overall health, not just weight loss.' Breaking Down Barriers to Participation The device, data, and service agreement specifically addresses socioeconomic challenges that have historically limited participation in employer weight management programs. By removing the complexity of manual tracking and providing technology that works regardless of geographic location, the solution serves remote populations with varying: Cultural preferences around health monitoring Technical comfort levels Geographic limitations Previous experiences with weight management programs Proven Results with Major Technology Companies Leading technology companies have already implemented 9amHealth's comprehensive program, recognizing weight care as an entry point to broader health support for employees with comorbidities. The addition of Smart Meter's cellular scales strengthens these deployments by providing: Consistent engagement through automated tracking Reduced administrative burden on HR teams Enhanced clinical outcomes through better data quality Improved employee satisfaction through simplified user experience Meeting Employees Where They Are Unlike traditional programs that require employees to repeat previous lifestyle interventions before accessing additional care, the 9amHealth solution meets each person where they are in their health journey. Smart Meter's Cellular scales support this philosophy by providing immediate, judgment-free data collection that integrates seamlessly with comprehensive care plans ranging from lifestyle coaching to GLP-1 prescriptions and bariatric surgery referrals when appropriate. About Smart Meter, LLC Smart Meter is the trusted supplier of Remote Patient Monitoring ('RPM') solutions. The company's technology and services empower a nationwide network of Smart Partners TM who are working directly with healthcare providers to transform patient care. Millions of vital health data readings are reliably delivered across the company's secure platform to enable real-time, better-informed health care. The company's proprietary patient-friendly cellular FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G network to ensure an engaging patient experience for improved adherence. For more information, visit About 9amHealth 9amHealth offers complete cardiometabolic care—a first-of-its-kind, whole-body approach to preventing and treating obesity, diabetes, high cholesterol, and hypertension. They partner with employers, health plans, and PBMs to provide effective health benefits for those living with chronic conditions. Their members receive personalized care plans, prescription delivery, at-home lab tests, and unlimited specialist access. 9amHealth was founded in 2021 by the team behind mySugr and is backed by 7Wire Ventures, Cigna Ventures, Human Capital, Founders Fund, and Define Ventures. Learn more at
